🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Botanical Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Bayberry
75 mg
Red Beet
75 mg
Yellow Dock
75 mg
35 mg
📊 Market median: 300.0mg (159 products)
Median 300.0mg This product: 35mg
Fennel
35 mg
35 mg
📊 Market median: 60.0mg (107 products) 📚 1 studies — no high-quality reviews
This product: 35mg
35 mg
📊 Market median: 250.0mg (337 products) 📚 125 studies (Tier A: 1, B: 41)
This product: 35mg
Wild Yam
35 mg
Blessed Thistle
35 mg
30 mg
📊 Market median: 500.0mg (497 products) 📚 132 studies (Tier A: 0, B: 40)
This product: 30mg

Other Ingredients

In a special base of the following:

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (80% of products) Nutrient (6% of products) No Claim (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions for use: One tablet daily, or as directed

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

TAMPER RESISTANT OUTER SEAL - DO NOT USE IF BROKEN.

🧪 Formulation Notes

Contains no added, starches, salt, sugar wheat, corn, yeast, soy, milk, or preservatives.

Additional Information

0931 MFG07/2010

FOR DISTRIBUTION BY HEALTH CARE PROFESSIONALS ONLY

Store in a cool, dry place.

Manufactured under strict GMP and USP guidelines.

Product # 1703-T

Product Details

DSLD Entry Date 2013-11-25
Product Type Botanical
Form Tablet or Pill
DSLD ID 27495
Data Updated 2026-04-11

Research Evidence

5 Research Sources
29 Avg Quality Score
5 Other
D Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy
Other Complementary therapies in medicine 2018
D Taraxacum mongolicum Hand.-Mazz. extract disrupts the interaction between triple-negative breast cancer cells and tumor-associated macrophages by inhibiting RAC2/NF-κB p65/p38 MAPK pathway
Other Journal of ethnopharmacology 2025
D Revealing the metabolic mechanism of dandelion extract against A549 cells using UPLC-QTOF MS
Other Biomedical chromatography : BMC 2022
D Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells
Other Scientific reports 2023
D Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways
Other Oncotarget 2016
View all evidence for Dandelion →

Compare Similar Products

View all Dandelion products →